JMP Securities Starts Intra-Cellular Therapies (ITCI) at Market Outperform
Tweet
Share
E-mailGet Alerts ITCI Hot Sheet
Price: $74.54 --0%
Rating Summary:
17 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 15 | Down: 10 | New: 13
Rating Summary:
17 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 15 | Down: 10 | New: 13
Join SI Premium – FREE
JMP Securities initiated coverage on Intra-Cellular Therapies (NASDAQ: ITCI) with a Market Outperform rating and a price target of $26.00.
For an analyst ratings summary and ratings history on Intra-Cellular Therapies click here. For more ratings news on Intra-Cellular Therapies click here.
Shares of Intra-Cellular Therapies closed at $17.03 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Intra-Cellular Therapies (ITCI) PT Raised to $107 at Canaccord Genuity
- Ambit Capital Starts Tata Technologies (TATATECH:IN) at Sell (4)
- HSBC Starts Auna SA (AUNA) at Buy, 'Just what the doctor prescribed'
Create E-mail Alert Related Categories
New CoverageRelated Entities
JMP SecuritiesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
